Vicor Technologies, Inc., a medical diagnostics company, focuses on commercializing noninvasive diagnostic technology products. It develops diagnostic technology products based on its patented and proprietary PD2i Algorithm, a point correlation dimension algorithm that facilitates the physicians to predict the future pathological events, such as autonomic nervous system dysfunction, cardiac mortality, and imminent death from trauma. The company develops its therapeutic products by using a drug discovery platform, which focuses on naturally occurring peptides and proteins derived from state-dependent physiologies, such as hibernation. Its products include PD2i Analyzer that displays and analyzes electrocardiographic information and measures heart rate variability in patients at rest, as well as in response to controlled exercise and paced respiration; and PD2i-VS, which is used to assess the severity of critically injured combat and civilian trauma casualties to determine the need for immediate life saving intervention in those victims who are at high risk of imminent death. The company sells its products through independent sales representatives and sales personnel to physicians in the United States, and Central and South America. Vicor Technologies, Inc. was founded in 2000 and is based in Boca Raton, Florida.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• No BuyIns.Net Alerts Available for VCRT